Glaucoma Treatment Market Worldwide Industry Analysis By Size, Trends And Segments Forecast To 2028

Precision Business Insights published a research report on “Glaucoma Treatment Market By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Congenital Glaucoma, Secondary Glaucoma, and Others), By Drug Class (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Carbonic Anhydrase Inhibitors, and Others), By Sales Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales), and Geography - Global/Region/Country Forecast to 2028”.

Glaucoma is known as the "silent thief of sight" because most kinds of the disease generate no discomfort or symptoms until significant vision loss occurs. Glaucoma is a collection of eye illnesses that develop when the optic nerve, which transmits information from the eye to the brain, is damaged. The majority of cases are linked to ocular hypertension, a condition in which the pressure inside the eye is higher than normal, although it can also happen when the intraocular pressure is normal. If left untreated, it causes peripheral vision loss, which then progresses to permanent blindness. Glaucoma is the world’s largest second largest cause of blindness. During normal eye exams, a tonometer is used to measure intraocular pressure (IOP). IOP should be less than 21 mmHg in most cases. Glaucoma treatment options include surgery, laser treatment, and medication, depending on the severity of the condition. The majority of eye drops are being used to reduce IOP, which is the initial line of defence against glaucoma. During the COVID-19 epidemic, the industry went through a number of changes, with initial prospects looking gloomy. In the first quarter of 2020, healthcare practitioners were forced to consign non-COVID-19 procedures to the back yard due to an exponential increase in infection cases.

View detailed report description here https://precisionbusinessinsights.com/market-reports/glaucoma-treatment-market/

The rise in the prevalence of glaucoma, increased initiatives to raise awareness about glaucoma, and technical breakthroughs in the field of ophthalmology are all driving the growth of the glaucoma treatment market. Glaucoma is quite common among diabetics and people who have additional visual problems such age-related macular degeneration (AMD), cataracts, and dry eye. In accordance with this, the growing senior population, which is more vulnerable to such disorders, is boosting market growth prospects. Furthermore, rising public awareness of health issues and a growing inclination for laser glaucoma surgery are propelling the market forward.

On the basis of Drug class, the market is segregated as Prostaglandin Analogs, Beta Blockers, Carbonic Anhydrase Inhibitors, Alpha Agonist, and Others. In terms of Disease Indication, the market is classified as Closed Angle Glaucoma, Open Angle Glaucoma, and Others.

Owing to the increased glaucoma incidences and improved healthcare infrastructure and services, North America is likely to have the greatest share of the market. In addition, numerous groups in the United States are raising public awareness about glaucoma.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=42467

Some of the major key players in the Glaucoma Treatment Market are Novartis AG, Akorn Incorporated, Inotek Pharmaceuticals, Aerie Pharmaceuticals Inc., Merck & Co., Inc., Pfizer Inc, Abbvie Inc. (Allergan Plc)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.